Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > LATEST
LATEST
-
BUSINESS Co-Promotions Dominate in Oncology, Diabetes Alliances: Fuji Keizai
April 24, 2026
-
REGULATORY War-Linked Supply Concerns Rise to 43 Cases, Focus Shifts to Solvents, Packaging
April 24, 2026
-
BUSINESS Medii, Pediatric Neurology Society Build System to Support Elevidys Use
April 24, 2026
-
BUSINESS Oncolys’ OBP-301 Wins US Fast Track Designation
April 24, 2026
-
BUSINESS Rituxan Biosimilar Expands Nephrotic Syndrome Indication in Japan
April 24, 2026
-
BUSINESS Japan OTC Drug Market Falls 2.5% to 117.1 Billion Yen in March: Intage
April 24, 2026
-
BUSINESS Genmab Targets 2027 US Debut for 2 Cancer Drugs, CEO Eyes Blockbuster Potential
April 23, 2026
-
BUSINESS Bayer Eyes 2026 Launch for Sevabertinib under “3-Plus-3” Strategy in Japan
April 23, 2026
-
REGULATORY JPMA Pushes for “Freeze” on On-Patent Drug Price Cuts at LDP Meeting
April 23, 2026
-
ORGANIZATION APAC Disbands Drug Discovery WG as Asia Capabilities Rise
April 23, 2026
-
ORGANIZATION Flight Cuts, Fuel Costs Tied to Iran Crisis Threaten API Imports: Trader
April 23, 2026
-
REGULATORY MHLW to Exclude High School-Age and Younger from OTC-Like Drug Charge: Official
April 23, 2026
-
REGULATORY Japan, Singapore to Share GMP Inspection Results under Cooperation Pact
April 23, 2026
-
BUSINESS iPark, Taiwan’s ITRI Ink MOU to Boost Biotech Collaboration
April 23, 2026
-
BUSINESS AbbVie, BioLabs Partner to Support Japan Biotech Startups
April 23, 2026
-
BUSINESS Lenvima-Keytruda Triplets Fail in First-Line RCC Trial
April 22, 2026
-
BUSINESS Another Global PIII Shuttered for Arcus-Partnered TIGIT Combo: Taiho
April 22, 2026
-
REGULATORY MHLW Orders Label Revisions for Remicade, Enbrel, Bavencio, and More Drugs
April 22, 2026
-
REGULATORY Extra Charges Likely for OTC-Like Drugs to Treat Seasonal Conditions: Minister
April 22, 2026
-
BUSINESS Imdelltra Likely to Gain Ground in 2nd-Line SCLC after Label Update: Oncologist
April 22, 2026
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…